Task: Answer the MCQ question.
Query: Which drug exhibits a -32.107% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
[a] COCCn1c(SCC(=O)Nc2ccc(Cl)cn2)nc2ccccc21
[b] O=C(OCC(=O)N1CCCC1)c1ccccc1OCc1ccccc1
[c] CCOC(=O)c1[nH]c2ccccc2c1NC(=O)c1cc(OC)c(OC)c(OC)c1
[d] O=C1CSC(c2ccccn2)N1Cc1cn2ccccc2n1
Answer: a. COCCn1c(SCC(=O)Nc2ccc(Cl)cn2)nc2ccccc21
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COCCn1c(SCC(=O)Nc2ccc(Cl)cn2)nc2ccccc21
COCCn1c(SCC(=O)Nc2ccc(Cl)cn2)nc2ccccc21
N-(5-chloropyridin-2-yl)-2-[1-(2-methoxyethyl)benzimidazol-2-yl]sulfanylacetamide